Global Ankylosing Spondylitis Treatment Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 103

Published Date: 18 Sep 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Ankylosing Spondylitis Treatment Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Ankylosing Spondylitis Treatment Drug size is estimated to be USD  million in 2026 from USD  million in 2020, with a change  % between 2020 and 2021. The global Ankylosing Spondylitis Treatment Drug market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
Ankylosing Spondylitis Treatment Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Non-steroidal Anti-inflammatory Drugs
    Inhibitor

Market segment by Application, can be divided into
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy
    Other

Market segment by players, this report covers
    Abbott
    Merck
    Eisai
    Novartis
    Pfizer
    Johson & Johson
    Abbive
    UCB
    Amgen
    Takeda
    Mitsubishi Tanabe
    Hisun Pharm
    Guojian Pharmaceutical
    Bio-Thera Solutions
    Maibo Pharma
    Celgen Pharm

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Ankylosing Spondylitis Treatment Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Ankylosing Spondylitis Treatment Drug, with revenue, gross margin and global market share of Ankylosing Spondylitis Treatment Drug from 2019 to 2021.
Chapter 3, the Ankylosing Spondylitis Treatment Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Ankylosing Spondylitis Treatment Drug market forecast, by regions, type and sales channel, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Ankylosing Spondylitis Treatment Drug research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Ankylosing Spondylitis Treatment Drug
    1.2 Classification of Ankylosing Spondylitis Treatment Drug by Type
        1.2.1 Overview: Global Ankylosing Spondylitis Treatment Drug Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Type in 2020
        1.2.3 Non-steroidal Anti-inflammatory Drugs
        1.2.4 Inhibitor
    1.3 Global Ankylosing Spondylitis Treatment Drug Market by Sales Channel
        1.3.1 Overview: Global Ankylosing Spondylitis Treatment Drug Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
        1.3.5 Other
    1.4 Global Ankylosing Spondylitis Treatment Drug Market Size & Forecast
    1.5 Global Ankylosing Spondylitis Treatment Drug Market Size and Forecast by Region
        1.5.1 Global Ankylosing Spondylitis Treatment Drug Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Ankylosing Spondylitis Treatment Drug Market Size by Region, (2016-2021)
        1.5.3 North America Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2016-2026)
        1.5.4 Europe Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2016-2026)
        1.5.6 South America Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Ankylosing Spondylitis Treatment Drug Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Ankylosing Spondylitis Treatment Drug Market Drivers
        1.6.2 Ankylosing Spondylitis Treatment Drug Market Restraints
        1.6.3 Ankylosing Spondylitis Treatment Drug Trends Analysis

2 Company Profiles
    2.1 Abbott
        2.1.1 Abbott Details
        2.1.2 Abbott Major Business
        2.1.3 Abbott Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.1.4 Abbott Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Abbott Recent Developments and Future Plans
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.2.4 Merck Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Merck Recent Developments and Future Plans
    2.3 Eisai
        2.3.1 Eisai Details
        2.3.2 Eisai Major Business
        2.3.3 Eisai Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.3.4 Eisai Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Eisai Recent Developments and Future Plans
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.4.4 Novartis Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Novartis Recent Developments and Future Plans
    2.5 Pfizer
        2.5.1 Pfizer Details
        2.5.2 Pfizer Major Business
        2.5.3 Pfizer Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.5.4 Pfizer Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Pfizer Recent Developments and Future Plans
    2.6 Johson & Johson
        2.6.1 Johson & Johson Details
        2.6.2 Johson & Johson Major Business
        2.6.3 Johson & Johson Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.6.4 Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Johson & Johson Recent Developments and Future Plans
    2.7 Abbive
        2.7.1 Abbive Details
        2.7.2 Abbive Major Business
        2.7.3 Abbive Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.7.4 Abbive Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Abbive Recent Developments and Future Plans
    2.8 UCB
        2.8.1 UCB Details
        2.8.2 UCB Major Business
        2.8.3 UCB Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.8.4 UCB Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 UCB Recent Developments and Future Plans
    2.9 Amgen
        2.9.1 Amgen Details
        2.9.2 Amgen Major Business
        2.9.3 Amgen Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.9.4 Amgen Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Amgen Recent Developments and Future Plans
    2.10 Takeda
        2.10.1 Takeda Details
        2.10.2 Takeda Major Business
        2.10.3 Takeda Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.10.4 Takeda Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Takeda Recent Developments and Future Plans
    2.11 Mitsubishi Tanabe
        2.11.1 Mitsubishi Tanabe Details
        2.11.2 Mitsubishi Tanabe Major Business
        2.11.3 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.11.4 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Mitsubishi Tanabe Recent Developments and Future Plans
    2.12 Hisun Pharm
        2.12.1 Hisun Pharm Details
        2.12.2 Hisun Pharm Major Business
        2.12.3 Hisun Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.12.4 Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Hisun Pharm Recent Developments and Future Plans
    2.13 Guojian Pharmaceutical
        2.13.1 Guojian Pharmaceutical Details
        2.13.2 Guojian Pharmaceutical Major Business
        2.13.3 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.13.4 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Guojian Pharmaceutical Recent Developments and Future Plans
    2.14 Bio-Thera Solutions
        2.14.1 Bio-Thera Solutions Details
        2.14.2 Bio-Thera Solutions Major Business
        2.14.3 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.14.4 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Bio-Thera Solutions Recent Developments and Future Plans
    2.15 Maibo Pharma
        2.15.1 Maibo Pharma Details
        2.15.2 Maibo Pharma Major Business
        2.15.3 Maibo Pharma Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.15.4 Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Maibo Pharma Recent Developments and Future Plans
    2.16 Celgen Pharm
        2.16.1 Celgen Pharm Details
        2.16.2 Celgen Pharm Major Business
        2.16.3 Celgen Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
        2.16.4 Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 Celgen Pharm Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Ankylosing Spondylitis Treatment Drug Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Ankylosing Spondylitis Treatment Drug Players Market Share
        3.2.2 Top 10 Ankylosing Spondylitis Treatment Drug Players Market Share
        3.2.3 Market Competition Trend
    3.3 Ankylosing Spondylitis Treatment Drug Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Ankylosing Spondylitis Treatment Drug Revenue and Market Share by Type (2016-2021)
    4.2 Global Ankylosing Spondylitis Treatment Drug Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Application (2016-2021)
    5.2 Ankylosing Spondylitis Treatment Drug Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2026)
    6.2 North America Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2026)
    6.3 North America Ankylosing Spondylitis Treatment Drug Market Size by Country
        6.3.1 North America Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2026)
        6.3.2 United States Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        6.3.3 Canada Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        6.3.4 Mexico Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2026)
    7.2 Europe Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2026)
    7.3 Europe Ankylosing Spondylitis Treatment Drug Market Size by Country
        7.3.1 Europe Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2026)
        7.3.2 Germany Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        7.3.3 France Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        7.3.5 Russia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        7.3.6 Italy Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2026)
    8.2 Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2026)
    8.3 Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size by Region
        8.3.1 Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Region (2016-2026)
        8.3.2 China Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        8.3.3 Japan Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        8.3.4 South Korea Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        8.3.5 India Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        8.3.7 Australia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2026)
    9.2 South America Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2026)
    9.3 South America Ankylosing Spondylitis Treatment Drug Market Size by Country
        9.3.1 South America Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2026)
        9.3.2 Brazil Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        9.3.3 Argentina Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2026)
    10.2 Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2026)
    10.3 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Country
        10.3.1 Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2026)
        10.3.2 Turkey Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)
        10.3.4 UAE Ankylosing Spondylitis Treatment Drug Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Ankylosing Spondylitis Treatment Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Ankylosing Spondylitis Treatment Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Ankylosing Spondylitis Treatment Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Ankylosing Spondylitis Treatment Drug Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region (2021-2026)
    Table 6. Abbott Corporate Information, Head Office, and Major Competitors
    Table 7. Abbott Major Business
    Table 8. Abbott Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 9. Abbott Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Merck Corporate Information, Head Office, and Major Competitors
    Table 11. Merck Major Business
    Table 12. Merck Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 13. Merck Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Eisai Corporate Information, Head Office, and Major Competitors
    Table 15. Eisai Major Business
    Table 16. Eisai Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 17. Eisai Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Novartis Corporate Information, Head Office, and Major Competitors
    Table 19. Novartis Major Business
    Table 20. Novartis Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 21. Novartis Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 23. Pfizer Major Business
    Table 24. Pfizer Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 25. Pfizer Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Johson & Johson Corporate Information, Head Office, and Major Competitors
    Table 27. Johson & Johson Major Business
    Table 28. Johson & Johson Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 29. Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Abbive Corporate Information, Head Office, and Major Competitors
    Table 31. Abbive Major Business
    Table 32. Abbive Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 33. Abbive Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. UCB Corporate Information, Head Office, and Major Competitors
    Table 35. UCB Major Business
    Table 36. UCB Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 37. UCB Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Amgen Corporate Information, Head Office, and Major Competitors
    Table 39. Amgen Major Business
    Table 40. Amgen Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 41. Amgen Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Takeda Corporate Information, Head Office, and Major Competitors
    Table 43. Takeda Major Business
    Table 44. Takeda Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 45. Takeda Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Mitsubishi Tanabe Corporate Information, Head Office, and Major Competitors
    Table 47. Mitsubishi Tanabe Major Business
    Table 48. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 49. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Hisun Pharm Corporate Information, Head Office, and Major Competitors
    Table 51. Hisun Pharm Major Business
    Table 52. Hisun Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 53. Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Guojian Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 55. Guojian Pharmaceutical Major Business
    Table 56. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 57. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Bio-Thera Solutions Corporate Information, Head Office, and Major Competitors
    Table 59. Bio-Thera Solutions Major Business
    Table 60. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 61. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Maibo Pharma Corporate Information, Head Office, and Major Competitors
    Table 63. Maibo Pharma Major Business
    Table 64. Maibo Pharma Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 65. Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 66. Celgen Pharm Corporate Information, Head Office, and Major Competitors
    Table 67. Celgen Pharm Major Business
    Table 68. Celgen Pharm Ankylosing Spondylitis Treatment Drug Product and Solutions
    Table 69. Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 70. Global Ankylosing Spondylitis Treatment Drug Revenue (USD Million) by Players (2019-2021)
    Table 71. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Players (2019-2021)
    Table 72. Breakdown of Ankylosing Spondylitis Treatment Drug by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 73. Ankylosing Spondylitis Treatment Drug Players Head Office, Products and Services Provided
    Table 74. Ankylosing Spondylitis Treatment Drug Mergers & Acquisitions in the Past Five Years
    Table 75. Ankylosing Spondylitis Treatment Drug New Entrants and Expansion Plans
    Table 76. Global Ankylosing Spondylitis Treatment Drug Revenue (USD Million) by Type (2016-2021)
    Table 77. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Type (2016-2021)
    Table 78. Global Ankylosing Spondylitis Treatment Drug Revenue Forecast by Type (2021-2026)
    Table 79. Global Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021)
    Table 80. Global Ankylosing Spondylitis Treatment Drug Revenue Forecast by Application (2021-2026)
    Table 81. North America Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2021) & (USD Million)
    Table 82. North America Ankylosing Spondylitis Treatment Drug Revenue by Type (2021-2026) & (USD Million)
    Table 83. North America Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021) & (USD Million)
    Table 84. North America Ankylosing Spondylitis Treatment Drug Revenue by Application (2021-2026) & (USD Million)
    Table 85. North America Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2021) & (USD Million)
    Table 86. North America Ankylosing Spondylitis Treatment Drug Revenue by Country (2021-2026) & (USD Million)
    Table 87. Europe Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2021) & (USD Million)
    Table 88. Europe Ankylosing Spondylitis Treatment Drug Revenue by Type (2021-2026) & (USD Million)
    Table 89. Europe Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021) & (USD Million)
    Table 90. Europe Ankylosing Spondylitis Treatment Drug Revenue by Application (2021-2026) & (USD Million)
    Table 91. Europe Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2021) & (USD Million)
    Table 92. Europe Ankylosing Spondylitis Treatment Drug Revenue by Country (2021-2026) & (USD Million)
    Table 93. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2021) & (USD Million)
    Table 94. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Type (2021-2026) & (USD Million)
    Table 95. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021) & (USD Million)
    Table 96. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Application (2021-2026) & (USD Million)
    Table 97. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Region (2016-2021) & (USD Million)
    Table 98. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue by Region (2021-2026) & (USD Million)
    Table 99. South America Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2021) & (USD Million)
    Table 100. South America Ankylosing Spondylitis Treatment Drug Revenue by Type (2021-2026) & (USD Million)
    Table 101. South America Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021) & (USD Million)
    Table 102. South America Ankylosing Spondylitis Treatment Drug Revenue by Application (2021-2026) & (USD Million)
    Table 103. South America Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2021) & (USD Million)
    Table 104. South America Ankylosing Spondylitis Treatment Drug Revenue by Country (2021-2026) & (USD Million)
    Table 105. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Type (2016-2021) & (USD Million)
    Table 106. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Type (2021-2026) & (USD Million)
    Table 107. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Application (2016-2021) & (USD Million)
    Table 108. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Application (2021-2026) & (USD Million)
    Table 109. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Country (2016-2021) & (USD Million)
    Table 110. Middle East & Africa Ankylosing Spondylitis Treatment Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Ankylosing Spondylitis Treatment Drug Picture
    Figure 2. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Type in 2020
    Figure 3. Non-steroidal Anti-inflammatory Drugs
    Figure 4. Inhibitor
    Figure 5. Ankylosing Spondylitis Treatment Drug Revenue Market Share by Sales Channel in 2020
    Figure 6. Hospital Pharmacy Picture
    Figure 7. Retail Pharmacy Picture
    Figure 8. Online Pharmacy Picture
    Figure 9. Other Picture
    Figure 10. Global Ankylosing Spondylitis Treatment Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 11. Global Ankylosing Spondylitis Treatment Drug Revenue and Forecast (2016-2026) & (USD Million)
    Figure 12. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region (2016-2026)
    Figure 13. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region in 2020
    Figure 14. North America Ankylosing Spondylitis Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Europe Ankylosing Spondylitis Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. South America Ankylosing Spondylitis Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Middle East and Africa Ankylosing Spondylitis Treatment Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Ankylosing Spondylitis Treatment Drug Market Drivers
    Figure 20. Ankylosing Spondylitis Treatment Drug Market Restraints
    Figure 21. Ankylosing Spondylitis Treatment Drug Market Trends
    Figure 22. Abbott Recent Developments and Future Plans
    Figure 23. Merck Recent Developments and Future Plans
    Figure 24. Eisai Recent Developments and Future Plans
    Figure 25. Novartis Recent Developments and Future Plans
    Figure 26. Pfizer Recent Developments and Future Plans
    Figure 27. Johson & Johson Recent Developments and Future Plans
    Figure 28. Abbive Recent Developments and Future Plans
    Figure 29. UCB Recent Developments and Future Plans
    Figure 30. Amgen Recent Developments and Future Plans
    Figure 31. Takeda Recent Developments and Future Plans
    Figure 32. Mitsubishi Tanabe Recent Developments and Future Plans
    Figure 33. Hisun Pharm Recent Developments and Future Plans
    Figure 34. Guojian Pharmaceutical Recent Developments and Future Plans
    Figure 35. Bio-Thera Solutions Recent Developments and Future Plans
    Figure 36. Maibo Pharma Recent Developments and Future Plans
    Figure 37. Celgen Pharm Recent Developments and Future Plans
    Figure 38. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Players in 2020
    Figure 39. Ankylosing Spondylitis Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 40. Global Top 3 Players Ankylosing Spondylitis Treatment Drug Revenue Market Share in 2020
    Figure 41. Global Top 10 Players Ankylosing Spondylitis Treatment Drug Revenue Market Share in 2020
    Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 43. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Type in 2020
    Figure 44. Global Ankylosing Spondylitis Treatment Drug Market Share Forecast by Type (2021-2026)
    Figure 45. Global Ankylosing Spondylitis Treatment Drug Revenue Share by Application in 2020
    Figure 46. Global Ankylosing Spondylitis Treatment Drug Market Share Forecast by Application (2021-2026)
    Figure 47. North America Ankylosing Spondylitis Treatment Drug Sales Market Share by Type (2016-2026)
    Figure 48. North America Ankylosing Spondylitis Treatment Drug Sales Market Share by Application (2016-2026)
    Figure 49. North America Ankylosing Spondylitis Treatment Drug Revenue Market Share by Country (2016-2026)
    Figure 50. United States Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Canada Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Mexico Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Europe Ankylosing Spondylitis Treatment Drug Sales Market Share by Type (2016-2026)
    Figure 54. Europe Ankylosing Spondylitis Treatment Drug Sales Market Share by Application (2016-2026)
    Figure 55. Europe Ankylosing Spondylitis Treatment Drug Revenue Market Share by Country (2016-2026)
    Figure 56. Germany Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. France Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. United Kingdom Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Russia Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Italy Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Asia-Pacific Ankylosing Spondylitis Treatment Drug Sales Market Share by Type (2016-2026)
    Figure 62. Asia-Pacific Ankylosing Spondylitis Treatment Drug Sales Market Share by Application (2016-2026)
    Figure 63. Asia-Pacific Ankylosing Spondylitis Treatment Drug Revenue Market Share by Region (2016-2026)
    Figure 64. China Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Japan Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. South Korea Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. India Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Southeast Asia Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Australia Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. South America Ankylosing Spondylitis Treatment Drug Sales Market Share by Type (2016-2026)
    Figure 71. South America Ankylosing Spondylitis Treatment Drug Sales Market Share by Application (2016-2026)
    Figure 72. South America Ankylosing Spondylitis Treatment Drug Revenue Market Share by Country (2016-2026)
    Figure 73. Brazil Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Argentina Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Middle East and Africa Ankylosing Spondylitis Treatment Drug Sales Market Share by Type (2016-2026)
    Figure 76. Middle East and Africa Ankylosing Spondylitis Treatment Drug Sales Market Share by Application (2016-2026)
    Figure 77. Middle East and Africa Ankylosing Spondylitis Treatment Drug Revenue Market Share by Country (2016-2026)
    Figure 78. Turkey Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Saudi Arabia Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. UAE Ankylosing Spondylitis Treatment Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abbott
Merck
Eisai
Novartis
Pfizer
Johson & Johson
Abbive
UCB
Amgen
Takeda
Mitsubishi Tanabe
Hisun Pharm
Guojian Pharmaceutical
Bio-Thera Solutions
Maibo Pharma
Celgen Pharm

Related Reports

Global Ankylosing Spondylitis Treatment Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Ankylosing Spondylitis Treatment Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 18 Jan 2022

date Pharma & Healthcare

The Ankylosing Spondylitis Treatment Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Ankylosing Spondylitis Treatment Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Ankylosing Spondylitis Treatment Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 11 Jan 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Ankylosing Spondylitis Treatment Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Ankylosing Spondylitis Treatment Drug Supply, Demand and Key Producers, 2023-2029

Global Ankylosing Spondylitis Treatment Drug Supply, Demand and Key Producers, 2023-2029

date 01 Feb 2023

date Pharma & Healthcare

The global Ankylosing Spondylitis Treatment Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Ankylosing Spondylitis Treatment Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Ankylosing Spondylitis Treatment Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Ankylosing Spondylitis Treatment Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Ankylosing Spondylitis Treatment Drug Supply, Demand and Key Producers, 2024-2030

Global Ankylosing Spondylitis Treatment Drug Supply, Demand and Key Producers, 2024-2030

date 09 Feb 2024

date Pharma & Healthcare

The global Ankylosing Spondylitis Treatment Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

ankylosing spondylitis treatment drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>